To further determine whether the rlipoE7m-MoGM-induced antitumor effect is CD8+ T cell dependent, TC-1 tumor-bearing mice were depleted of CD8+ T cells using an anti-CD8α antibody one day before i.t. immunization. The gene discussed is CD8A; the disease is neoplasm.